<DOC>
	<DOCNO>NCT02550717</DOCNO>
	<brief_summary>To investigate risk major bleeding ( include gastrointestinal intracranial bleeding episode ) among new user low-dose acetylsalicylic acid ( ASA ) clinical practice</brief_summary>
	<brief_title>Epidemiological Study Safety Aspirin The Health Improvement Network ( THIN )</brief_title>
	<detailed_description>These base population-based cohort use data primary care database UK : The Health Improvement Network ( THIN ) serve make clinically meaningful benefit-risk assessment regard major bleeding consequence ASA exposure general population .</detailed_description>
	<mesh_term>Heart Diseases</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Aspirin</mesh_term>
	<mesh_term>Salicylates</mesh_term>
	<mesh_term>Clopidogrel</mesh_term>
	<mesh_term>Anticoagulants</mesh_term>
	<mesh_term>Salicylic Acid</mesh_term>
	<criteria>Aged 4084 year Enrolled Primary Care Physician ( PCP ) least 2 year , To history computerized prescription least 1 year prior To least one encounter/visit record last three year To expose low dose ASA enter study Having diagnosis cancer enter study Having diagnosis alcohol abuse enter study Having diagnosis coagulopathies enter study Having diagnosis esophageal varix enter study Having diagnosis chronic liver disease enter study</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>84 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Low-dose Acetylsalicylic Acid ,</keyword>
	<keyword>Bleeding ,</keyword>
	<keyword>The Health Improvement Network ( THIN ) ,</keyword>
	<keyword>Cardiovascular</keyword>
	<keyword>Secondary prevention cardiovascular event</keyword>
</DOC>